Global Blepharitis Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 98

Report ID: 19062

Blepharitis is a chronic condition that is caused by chronic inflammation of the eyelid. It is a common eye disorder that is caused either by bacterial infection or skin condition (dandruff on scalp or acne rosacea). This is not a contagious disease condition and generally does not cause a permanent damage to the eye. Blepharitis is a common eye condition that leads the eyelid to redden, swollen and appears scaly at the base of the eye lashes. A dysfunction of the oil glands in eye lid due to hormone imbalance leads to blepharitis. Burning of the eye, sensitivity to light, blurred vision, dry eyes and crusting of eyelashes are some of the common symptoms observed in the patient suffering from blepharitis.
The global blepharitis market is majorly driven by rising prevalence of ophthalmological disorders, such as dry eye, uveitis among others. Additionally, factors such as government initiatives, rising demand for advanced treatment, increasing awareness among mass regarding eye care, and growing market players offering newer products for the treatment of blepharitis are likely to drive the market. Similarly, the involvement of leading players in new product development and upgrading their existing products to boost their product portfolio is boosting the growth of global blepharitis market.
North America and Europe dominates the global blepharitis therapeutics market owing to rising healthcare awareness and increasing disposable income in these regions. In addition, Asia-Pacific region is expected to grow at the highest CAGR due to increasing healthcare awareness and huge untapped customer in this region.
In 2018, the global Blepharitis market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Blepharitis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Blepharitis development in United States, Europe and China.

The key players covered in this study
Merck
Gelderma
Novartis
Lux Biosciences
InSite Vision Incorporated
Foamix
LABORATORIES THEA
Kala Pharmaceuticals

Market segment by Type, the product can be split into
Anterior Blepharitis
Posterior Blepharitis
Mixed Blepharitis

Market segment by Application, split into
Hospitals
Specialty Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Blepharitis status, future forecast, growth opportunity, key market and key players.
To present the Blepharitis development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Blepharitis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Blepharitis Market Size Growth Rate by Type (2014-2025)
1.4.2 Anterior Blepharitis
1.4.3 Posterior Blepharitis
1.4.4 Mixed Blepharitis
1.5 Market by Application
1.5.1 Global Blepharitis Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Specialty Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Blepharitis Market Size
2.2 Blepharitis Growth Trends by Regions
2.2.1 Blepharitis Market Size by Regions (2014-2025)
2.2.2 Blepharitis Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Blepharitis Market Size by Manufacturers
3.1.1 Global Blepharitis Revenue by Manufacturers (2014-2019)
3.1.2 Global Blepharitis Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Blepharitis Market Concentration Ratio (CR5 and HHI)
3.2 Blepharitis Key Players Head office and Area Served
3.3 Key Players Blepharitis Product/Solution/Service
3.4 Date of Enter into Blepharitis Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Blepharitis Market Size by Type (2014-2019)
4.2 Global Blepharitis Market Size by Application (2014-2019)

5 United States
5.1 United States Blepharitis Market Size (2014-2019)
5.2 Blepharitis Key Players in United States
5.3 United States Blepharitis Market Size by Type
5.4 United States Blepharitis Market Size by Application

6 Europe
6.1 Europe Blepharitis Market Size (2014-2019)
6.2 Blepharitis Key Players in Europe
6.3 Europe Blepharitis Market Size by Type
6.4 Europe Blepharitis Market Size by Application

7 China
7.1 China Blepharitis Market Size (2014-2019)
7.2 Blepharitis Key Players in China
7.3 China Blepharitis Market Size by Type
7.4 China Blepharitis Market Size by Application

8 Japan
8.1 Japan Blepharitis Market Size (2014-2019)
8.2 Blepharitis Key Players in Japan
8.3 Japan Blepharitis Market Size by Type
8.4 Japan Blepharitis Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Blepharitis Market Size (2014-2019)
9.2 Blepharitis Key Players in Southeast Asia
9.3 Southeast Asia Blepharitis Market Size by Type
9.4 Southeast Asia Blepharitis Market Size by Application

10 India
10.1 India Blepharitis Market Size (2014-2019)
10.2 Blepharitis Key Players in India
10.3 India Blepharitis Market Size by Type
10.4 India Blepharitis Market Size by Application

11 Central & South America
11.1 Central & South America Blepharitis Market Size (2014-2019)
11.2 Blepharitis Key Players in Central & South America
11.3 Central & South America Blepharitis Market Size by Type
11.4 Central & South America Blepharitis Market Size by Application

12 International Players Profiles
12.1 Merck
12.1.1 Merck Company Details
12.1.2 Company Description and Business Overview
12.1.3 Blepharitis Introduction
12.1.4 Merck Revenue in Blepharitis Business (2014-2019)
12.1.5 Merck Recent Development
12.2 Gelderma
12.2.1 Gelderma Company Details
12.2.2 Company Description and Business Overview
12.2.3 Blepharitis Introduction
12.2.4 Gelderma Revenue in Blepharitis Business (2014-2019)
12.2.5 Gelderma Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Blepharitis Introduction
12.3.4 Novartis Revenue in Blepharitis Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Lux Biosciences
12.4.1 Lux Biosciences Company Details
12.4.2 Company Description and Business Overview
12.4.3 Blepharitis Introduction
12.4.4 Lux Biosciences Revenue in Blepharitis Business (2014-2019)
12.4.5 Lux Biosciences Recent Development
12.5 InSite Vision Incorporated
12.5.1 InSite Vision Incorporated Company Details
12.5.2 Company Description and Business Overview
12.5.3 Blepharitis Introduction
12.5.4 InSite Vision Incorporated Revenue in Blepharitis Business (2014-2019)
12.5.5 InSite Vision Incorporated Recent Development
12.6 Foamix
12.6.1 Foamix Company Details
12.6.2 Company Description and Business Overview
12.6.3 Blepharitis Introduction
12.6.4 Foamix Revenue in Blepharitis Business (2014-2019)
12.6.5 Foamix Recent Development
12.7 LABORATORIES THEA
12.7.1 LABORATORIES THEA Company Details
12.7.2 Company Description and Business Overview
12.7.3 Blepharitis Introduction
12.7.4 LABORATORIES THEA Revenue in Blepharitis Business (2014-2019)
12.7.5 LABORATORIES THEA Recent Development
12.8 Kala Pharmaceuticals
12.8.1 Kala Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Blepharitis Introduction
12.8.4 Kala Pharmaceuticals Revenue in Blepharitis Business (2014-2019)
12.8.5 Kala Pharmaceuticals Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details